Multi-omics Mendelian randomization to identify novel immune therapeutic targets in benign prostatic hyperplasia

Zhenpeng Zhu1,2,3,4, Xing Ji1,2,3,4, Wenyuan Leng1,2,3,4

  • 1Department of Urology, Peking University First Hospital, Beijing 100034, China.

Genes & Diseases
|March 27, 2026
PubMed
Abstract

No abstract available in PubMed .